Complexation study and anticellular activity enhancement by doxorubicin-cyclodextrin complexes on a multidrug-resistant adenocarcinoma cell line
- 1 April 1999
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 9 (8) , 1115-1120
- https://doi.org/10.1016/s0960-894x(99)00150-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The design and development of DaunoXome® for solid tumor targeting in vivoAdvanced Drug Delivery Reviews, 1997
- Targeted Delivery of Doxorubicin via Sterically Stabilized Immunoliposomes: Pharmacokinetics and Biodistribution in Tumor-bearing MicePharmaceutical Research, 1996
- Anthracycline Antibiotics in Cancer TherapyDrugs, 1994
- Recognition ability and cytotoxicity of some oligosaccharidylsubstituted β‐cyclodextrinsBiology of the Cell, 1994
- Multidrug resistance during cancer chemotherapy — biotechnological solutions to a clinical problemTrends in Biotechnology, 1993
- Cure of Xenografted Human Carcinomas by BR96-Doxorubicin ImmunoconjugatesScience, 1993
- Cyclodextrins and their applications in analytical chemistryChemical Reviews, 1992
- Sensitization of multidrug-resistant colon cancer cells to doxorubicin encapsulated in liposomesCancer Chemotherapy and Pharmacology, 1991
- Inclusion complexation of doxorubicin and daunorubicin with cyclodextrinsJournal of Pharmaceutical and Biomedical Analysis, 1990